Cheplapharm Arzneimittel GmbH

BRIEF

published on 12/16/2024 at 08:53, 5 days 5 hours ago

CHEPLAPHARM Acquires Gemzar from Lilly

Acquisition Oncology Eli Lilly CHEPLAPHARM Gemzar
PRESS RELEASE

published on 12/16/2024 at 08:48, 5 days 5 hours ago

CHEPLAPHARM acquires Gemzar from Lilly
CHEPLAPHARM acquires Gemzar from Lilly, expanding its oncology portfolio with a proven chemotherapeutic agent for various types of cancer

Acquisition Oncology CHEPLAPHARM Chemotherapy Gemzar
BRIEF

published on 11/08/2024 at 10:50, 1 month 13 days ago

Sebastian Braun Honored as EY Entrepreneur of the Year

Entrepreneurship Family Business CHEPLAPHARM EY Award Sebastian Braun
PRESS RELEASE

published on 11/08/2024 at 10:45, 1 month 13 days ago

SEBASTIAN BRAUN WINS EY ENTREPRENEUR OF THE YEAR
Sebastian Braun, Chairman of CHEPLAPHARM Group, wins EY Entrepreneur of the Year in 'family business' category. Recognized for outstanding leadership and business growth

Entrepreneurship Business Award EY Entrepreneur Of The Year Sebastian Braun CHEPLAPHARM Group
BRIEF

published on 07/17/2024 at 12:19, 5 months 4 days ago

CHEPLAPHARM Reorganizes Management Team

Pharmaceutical Supply Chain Management Corporate Development CHEPLAPHARM
PRESS RELEASE

published on 07/17/2024 at 12:14, 5 months 4 days ago

CHEPLAPHARM reorganises Management Team
CHEPLAPHARM reorganises Management Team with new appointments and expanded responsibilities, preparing for the future. Artem Gevorkyan joins as Managing Director Corporate Business Development, Karl Lang leads Supply Chain & Logistics, Klaus Köhl leaves company

Management Team Reorganization CHEPLAPHARM Artem Gevorkyan Karl Lang
BRIEF

published on 04/26/2024 at 12:00, 7 months 25 days ago

CHEPLAPHARM Reports Record Revenue and Growth in Financial Year 2023

Pharmaceutical Industry Acquisitions Financial Growth Corporate Bonds CHEPLAPHARM
PRESS RELEASE

published on 04/26/2024 at 11:55, 7 months 25 days ago

CHEPLAPHARM closes financial year 2023 with record revenue and double-digit growth
CHEPLAPHARM reports record revenue of €1.5 billion and 17% year-over-year growth in financial year 2023. EBITDA up 14% to €780.5 million with stable 52% margin. Expansion with new affiliates in Japan and Switzerland

EBITDA Revenue Acquisitions Growth CHEPLAPHARM
BRIEF

published on 04/03/2024 at 10:15, 8 months 18 days ago

Caroline Jacquin appointed Managing Director of CHEPLAPHARM France SAS

Pharmaceutical Industry Managing Director Leadership Change Caroline Jacquin CHEPLAPHARM France SAS
PRESS RELEASE

published on 04/03/2024 at 10:10, 8 months 18 days ago

Caroline Jacquin appointed Managing Director of CHEPLAPHARM France SAS
Caroline Jacquin appointed Managing Director of CHEPLAPHARM France SAS, experienced pharmaceutical manager with 25 years in leading positions to lead the French subsidiary. Isabelle Dalle retiring

Pharmaceutical Industry Managing Director Caroline Jacquin CHEPLAPHARM France SAS Isabelle Dalle

Published on 12/21/2024 at 01:30, 12 hours 46 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 12 hours 46 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 14 hours 11 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 14 hours 16 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 14 hours 46 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 13 hours 25 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 13 hours 31 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 19 hours 6 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 19 hours 20 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 20 hours 16 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 1 hour 59 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 20 hours 16 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 20 hours 21 minutes ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 1 day 19 hours ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News